JEFFERSON CITY, Mo. (AP) –– Some are calling it a “game-changer” in the battle against methamphetamine labs a new form of pseudoephedrine that apparently can’t be used to make the dangerous and addictive drug.

The formulation known as Tarex was developed by Highland Pharmaceuticals, a suburban St. Louis company that hopes to have it on the market by summer under the brand name Releva.

Some narcotics officers believe Releva holds promise in turning the tide against meth labs.

A key to meth-making is crystallization. Highland Pharmaceuticals says that rather than crystallizing when heated with chemicals used in meth-making, Tarex results in a gooey substance.

A Missouri House committee on Wednesday heard testimony on a proposal to require a prescription for pseudoephedrine, but it would exempt products that can’t be turned into meth.

(© Copyright 2012 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)

  1. bonniej125 says:

    Reblogged this on Crazy ~ Beautiful~ Addicted and commented:
    This would be amazing but I know they would figure out something else to take its place or make new drugs. Drugs are never going to go away, I have learned to deal with that.

Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

More From CBS St. Louis

Download The App

Listen Live